CD20 antibodies induce production and release of reactive oxygen species by neutrophils

Blood

Volumn 123, Issue 25, 2014, Pages 4001-4002

  Werlenius, Olle ^a   Riise, Rebecca E ^a   Simpanen, Maria ^a   Aurelius, Johan ^a   Thorén, Fredrik B ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OFATUMUMAB; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; HUMAN; IN VIVO STUDY; LETTER; LEUKEMIA CELL; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; APOPTOSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME INHIBITORS; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LUMINESCENT MEASUREMENTS; NADPH OXIDASE; NEUTROPHILS; ONIUM COMPOUNDS; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 84902665683     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-05-574285     Document Type: Letter

References (6)

1. Golay J, Da Roit F, Bologna L, et al. Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab. Blood. 2013;122(20):3482-3491.
2. Bylund J, Björnsdottir H, Sundqvist M, Karlsson A, Dahlgren C. Measurement of respiratory burst products, released or retained, during activation of professional phagocytes. Methods Mol Biol. 2014;1124:321-338.
3. Dall'Ozzo S, Tartas S, Paintaud G, et al. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship. Cancer Res. 2004;64(13):4664-4669. (Pubitemid 38856941)
4. Golay J, Manganini M, Facchinetti V, et al. Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2. Haematologica. 2003;88(9):1002-1012. (Pubitemid 37151151)
5. Hellstrand K, Asea A, Dahlgren C, Hermodsson S. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites. J Immunol. 1994;153(11):4940-4947. (Pubitemid 24356125)
6. Thorén FB, Romero AI, Hermodsson S, Hellstrand K. The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death. J Immunol. 2007;179(2):781-785.